Voltage-gated sodium channels are essential for the propagation of action potentials in nociceptive neurons.
peak current at all voltages; and 3) OD1 induces a substantial persistent current. Na v 1.8 was not affected by concentrations up to 2 M, whereas Na v 1.3 was sensitive only to concentrations higher than 100 nM. OD1 impairs the inactivation process of Na v 1.3 with an EC 50 value of 1127 nM. Finally, the effects of OD1 were compared with a classic ␣-toxin, AahII from Androctonus australis Hector and a classic ␣-like toxin, BmK M1 from Buthus martensii Karsch. At a concentration of 50 nM, both toxins affected Na v 1.7. Na v 1.3 was sensitive to AahII but not to BmK M1, whereas Na v 1.8 was affected by neither toxin. In conclusion, the present study shows that the scorpion toxin OD1 is a potent modulator of Na v 1.7, with a unique selectivity pattern.
Voltage-gated sodium channels (VGSC) are the signature channels of excitable cells. The channels are large and complex proteins that open transiently upon membrane depolarization, giving the upstroke of the action potential. They consist of a pore forming ␣-subunit and auxiliary ␤-subunits. So far, 10 mammalian ␣-subunits (Na v 1.1-Na v 1.9, Na x ) and four ␤-subunits have been cloned. The ␤-subunits modulate the localization, expression, and functional properties of ␣-subunits (Catterall et al., 2005) . Different ␣-subunits have distinct electrophysiological and pharmacological properties, and they are targeted by a large variety of chemically different toxins from animal venoms and plants . Many loss-of-function and gain-of-function mutations of ␣-subunits have been identified in human conditions characterized with epilepsy, seizures, ataxia, and increased sensitivity to pain (Meisler and Kearney, 2005) .
Physiological and pharmacological evidence has demonstrated a critical role for VGSCs in many types of pain syndromes . Two VGSCs, Na v 1.8 and Na v 1.9, are expressed selectively in damage-sensing peripheral neurons, whereas a third channel, Na v 1.7, is found predominantly in sensory and sympathetic neurons and is implicated in inflammatory pain. An embryonic channel, Na v 1.3, is also up-regulated in damaged peripheral nerves and associated with increased electrical excitability in neuropathic pain states. A combination of antisense and knock-out studies support a specialized role for these VGSCs in pain pathways, and pharmacological studies with some peptidyl toxins suggest that isoform-specific antagonists should be feasible and therefore could be useful analgesics .
In addition to its role in inflammatory pain (Nassar et al., 2004; Yeomans et al., 2005) , Na v 1.7 has been implicated in other pathophysiological conditions. Recent work has shown that autosomal dominant erythermalgia is associated with mutations in this VGSC Drenth et al., 2005; Michiels et al., 2005; Waxman and Dib-Hajj, 2005) . Furthermore, functional expression of Na v 1.7 has been linked with strong metastatic potential in prostate cancer, and this channel has been suggested to be a functional diagnostic marker (Diss et al., 2005) . Despite its clinical importance, the pharmacological characterization of Na v 1.7 is not very elaborate, and a selective high-affinity modulator is still missing. The local anesthetic and class I antiarrhythmic lidocaine, a well known VGSC modulator, decreases Na v 1.7 currents in a frequency-dependent matter, with an EC 50 value of 450 M (Chevrier et al., 2004) . In addition, recent work showed that the T-type Ca 2ϩ channel antagonist mibefradil is a state-dependent VGSC modulator, blocking Na v 1.2, Na v 1.4, Na v 1.5, and Na v 1.7 at low micromolar concentrations (McNulty and Hanck, 2004) . Two tarantula peptides, ProTx-I and ProTx-II, isolated from Thrixopelma pruriens, inhibit activation of Na v 1.2, Na v 1.5, Na v 1.7, and Na v 1.8 in the nanomolar range (Middleton et al., 2002) . Heinemann and coworkers demonstrated that the scorpion ␣-toxins Lqh-2 and Lqh-3 from Leiurus quinquestriatus hebraeus, previously described as potent modulators of Na v 1.5 (Chen and Heinemann, 2001 ) and Na v 1.4 , impair the inactivation process of Na v 1.7 at low nanomolar concentrations .
In the field of scorpion toxinology, the Asian scorpion Buthus martensii Karsch has received notable attention with reference to pain. A number of analgesic peptides from its venom have been reported; for most of them, it can be assumed that they could target VGSCs by virtue of their primary structure homology and similar scaffold with so-called long-chain sodium channel toxins (Goudet et al., 2002) . They are: BmK ITAP, an excitatory insect-selective toxin (Xiong et al., 1999) ; BmK dITAP3, a depressant insect-selective toxin (Guan et al., 2001a) with an analgesic effect in mice; BmK AGAP, an antitumor analgesic peptide showing inhibitory effect on both visceral and somatic pain (Liu et al., 2003) ; BmK Ang P1 (Guan et al., 2001b) ; BmK AngM1 (Cao et al., 2004) ; BmK AS (Chen and Ji, 2002) ; BmK IT2 ; BmK I1; BmK I4; and BmK I6 (Guan et al., 2000) . All of these are peptides for which analgesic properties in mice have been demonstrated. These findings indicate that scorpion toxins can be a valuable source of potential analgesics.
In the present study, we investigated the effect of the recently discovered scorpion toxin OD1 (Fig. 1) , on three VGSCs implicated in pain sensation (i.e., Na v 1.3, Na v 1.7, and Na v 1.8). Most scorpion neurotoxins targeting VGSCs are single-chain polypeptides composed of 60 to 70 amino acids cross-linked by 4-disulfide bridges. They comprise two main groups: ␣-and ␤-toxins (Possani et al., 1999) . Scorpion ␣-toxins bind to site 3 and slow down the inactivation process.
According to their different pharmacological and binding properties, the ␣-toxins can be further divided into three subgroups: classic ␣-toxins, ␣-like toxins, and insect ␣-toxins. Classic ␣-toxins (e.g., AahII, Lqh-2) are highly toxic to mammals, whereas the insect ␣-toxins (e.g., Lqh␣IT) are highly toxic to insects. The ␣-like toxins (e.g., Lqh-3, BmK M1) act on both mammals and insects (Gordon et al., 1996; Goudet et al., 2002; Rodriguez de la Vega and Possani, 2005) . OD1 is the first toxin isolated from the Iranian yellow scorpion Odonthobuthus doriae and was recently characterized as an ␣-like toxin. Jalali et al. (2005) showed that the inactivation process of the insect channel, para/tipE, was severely hampered by 200 nM OD1 (EC 50 ϭ 80 Ϯ 14 nM), whereas Na v 1.2/␤ 1 still was not affected at concentrations up to 5 M. Na v 1.5/␤ 1 was influenced only at micromolar concentrations (Jalali et al., 2005) .
Materials and Methods

Sodium Channel Expression in Xenopus laevis
Oocytes. For in vitro transcription, r␤ 1 /pSP64T was first linearized with EcoRI. Next, capped cRNAs were synthesized from the linearized plasmid using the large-scale SP6 mMESSAGE mMACHINE transcription kit (Ambion, Austin, TX). The hNav1.8/pBSTA, rNav1.7/pBSTA, rNav1.3/pNa3T, and h␤ 1 /pGEM-HE vectors were linearized with NotI, SacII, NotI, and NheI, respectively, and transcribed with the T7 mMESSAGE-mMACHINE kit.
The harvesting of oocytes from anesthetized female X. laevis frogs was performed as described previously (Tytgat et al., 1997) . Oocytes were injected with 50 nl of cRNA at a concentration of 1 ng/nl using a microinjector (Drummond Scientific, Broomall, PA). The solution used for incubating the oocytes (ND-96 solution) contained 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl 2 , 2 mM MgCl 2 , and 5 mM HEPES, pH 7.4, supplemented with 50 mg/l gentamicin sulfate and 180 mg/l theophylline (except for Na v 1.7).
Electrophysiological Measurements. Sodium currents were recorded using the X. laevis expression system. Two-electrode voltage-clamp recordings were performed at room temperature (18-22°C) using a GeneClamp 500 amplifier controlled by a pClamp data acquisition system (Molecular Devices, Sunnyvale, CA). Whole-cell currents from oocytes were recorded 2 to 4 days after injection. Current and voltage electrodes had resistances as low as possible (0.2-1 M⍀) and were filled with 3 M KCl. Currents were sampled at 5 kHz and filtered at 1 kHz using a four-pole low-pass Bessel filter. Leak subtraction was performed using a ϪP/4 protocol. To eliminate the effect of the voltage drop across the bath-grounding electrode, the bath potential was actively controlled. Voltage records were carefully monitored on an oscilloscope (HAMEG Instruments GmbH, Mainhausen, Germany).
The bath solution was ND-96 solution. Toxins were added directly to the recording chamber from a stock solution in ND-96 to obtain the desired final concentration. Immediately after adding the toxin stock solution at some distance from the oocyte, the bath solution was mixed to obtain a homogenous final concentration within a few seconds.
For activation protocols, 100-ms test depolarizations ranging from Ϫ45 to ϩ70 mV were applied from a holding potential of Ϫ100 mV in 
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5-mV increments, at an interval of 5 s. Voltage-dependent steadystate inactivation was determined by means of a double-pulse protocol in which a conditioning pulse was applied from a holding potential of Ϫ100 mV to a range of potentials from Ϫ90 (or Ϫ70) mV to 0 (or Ϫ5) mV in 5-mV increments for 50 ms, immediately followed by a test pulse to 0 (or Ϫ5) mV. The peak current amplitudes during the tests were normalized to the amplitude of the first pulse and plotted against the potential of the conditioning pulse. The voltage dependence of the relative current (activation and fast inactivation) was fit by a Boltzmann function. Recovery from fast inactivation was examined using a standard double-pulse protocol. A 25-ms conditioning pulse to 0 mV was used to fully fast-inactivate the channel. The membrane was then hyperpolarized to Ϫ100 mV from 0 to 160 ms, and the recovery was monitored by measuring the relative peak Na ϩ current elicited by a second pulse to 0 mV. The interval between the pulses was 5 s. The recovery of the peak amplitude was fitted with a double exponential. Data were analyzed in Winascd (Guy Droogmans, Katholieke Universiteit, Leuven, Belgium) and in Origin (OriginLab Corp., Northampton, MA).
Quantification of Toxin Effects. To assay the complex effects of the toxin, two parameters were determined: 1) the increased influx of Na ϩ ions at different voltages was quantified by measuring the area under the current-voltage (I-V) curve (AUC) in control conditions and in the presence of the toxin, and 2) the degree of fast inactivation was assayed by measuring the peak current as well as the current amplitude at 30 ms after the start of the depolarization. The ratio I 30ms /I peak gives an estimate for the fast inactivation process and similar parameters have been used by others as a measure of fast inactivation .
The dose dependence for toxin-induced effects was measured by plotting the parameter I 30ms /I peak as a function of toxin concentration. The concentration dependence was described with the following dose-response equation:
nH ]}, where n H is the Hill coefficient, [toxin] is the toxin concentration, and EC 50 is the concentration of half-maximal effect. A 1 is the offset and was determined from experiments in the absence of toxin ([toxin] ϭ 0). For fitting the data, the A 1 value was fixed to the value obtained under control conditions. The value A 2 is measured for the maximal effect of the toxin and was determined from the fits.
Results
Differential Effects of OD1 on Na v 1.7, Na v 1.3, and Na v 1.8. Figure 2 shows representative whole-cell Na ϩ currents recorded from oocytes expressing Na v 1.7, Na v 1.3, and molpharm.aspetjournals.org Na v 1.8 in control conditions (top) and in the presence of 50 nM (Na v 1.7), 100 nM (Na v 1.3), and 1000 nM (Na v 1.8) OD1 (middle). Na ϩ currents were evoked by applying a series of depolarizing voltage steps between Ϫ45 and ϩ70 mV in 5-mV increments. The bottom shows the corresponding I-V curves in control conditions (f) and in the presence of OD1 (Ⅺ).
Compared with control conditions, 50 nM OD1 has dramatic effects on Na v 1.7 currents: 1) the inactivation is impaired, 2) there is a substantial persistent current at the end of the 100-ms voltage step, and 3) there is an increase in inward peak current. This last effect is visible at all voltages and was quantified by measuring the AUC. OD1 (50 nM) increases the AUC with 170 Ϯ 10% (n ϭ 4). The impairment of the inactivation process becomes clear by comparing the current amplitude at 30 ms (vertical arrow) for control conditions and in the presence of 50 nM OD1. The inset shows the corresponding I 30ms -voltage relation. At 50 nM OD1, Na v 1.3 and Na v 1.8 were not affected. Na v 1.8 is completely insensitive to 1000 nM OD1, whereas Na v 1.3 was unaffected by concentrations up to 100 nM. Na v 1.3 is affected by higher concentrations of OD1. The modulation of Na v 1.3 by 500 nM OD1 is less dramatic but similar to the effects of 50 nM OD1 to Na v 1.7: there is an increase in peak current, a larger persistent current at the end of the test pulse and an impairment of the fast inactivation process.
We used this last parameter to quantify and compare the effects of OD1 on these two VGSCs. Figure 3 shows the relative I 30ms /I peak in function of increasing concentrations of OD1 for Na v 1.7 (squares) and Na v 1.3 (circles). Each data point represents the mean Ϯ S.E.M. (n ϭ 3-6). The dotted line represents the best fit of the data to the dose-response equation described above. The EC 50 value and Hill coefficient were 4.5 Ϯ 0.2 nM and 1.5 Ϯ 0.1, respectively, for Na v 1.7 and 1127 Ϯ 263 nM and 1.1 Ϯ 0.2, respectively, for Na v 1.3. These values demonstrate that OD1 displays a selectivity for Na v 1.7.
Effects of OD1 on the Gating of Na v 1.7 and Na v 1.3. The availability of Na ϩ channels upon depolarization is dependent on the cell membrane resting potential. Fewer channels become available as the resting membrane potential progressively moves toward more depolarized voltages. This effect is due to the accumulation of channels in the nonconducting inactivated state. This phenomenon was measured experimentally using constant conditioning pulses to voltages between Ϫ90 and 0 mV. The fraction of available current left was measured by standard test pulses (0 mV for Na v 1.7 and Ϫ5 mV for Na v 1.3). The normalized currents were then plotted against the conditioning voltage in the absence and presence of OD1 (Fig. 4 , top, Na v 1.7; bottom, Na v 1.3). OD1 (50 nM) does not significantly shift the V 1/2 of Fig. 3 . Na v 1.7 and Na v 1.3 have different sensitivities to OD1. Doseresponse curves for OD1 on Na v 1.7 (f) and Na v 1.3 (F) channels obtained by plotting the relative I 30ms /I peak values in function of the toxin concentrations, fitted with the dose-response equation under Quantification of Toxin Effects yielding an EC 50 value and Hill coefficient. For Na v 1.7, these values were 4.5 Ϯ 0.2 nM and 1.5 Ϯ 0.1, respectively. For Na v 1.3, they were 1127 Ϯ 263 nM and 1.1 Ϯ 0.2, respectively. Each data point is an average from three to six experiments. Fig. 4 . Effect of OD1 on the activation and steady-state inactivation curves of Na v 1.7 (top) and Na v 1.3 (bottom). Activation curves (squares) were derived from the same family of currents used for the currentvoltage curves (Fig. 2) using the standard procedure (see Materials and Methods). Steady-state inactivation curves (circles) were determined using conditioning pulses to voltages between Ϫ90 and 0 mV and a standard test pulse to 0 mV for Na v 1.7 or Ϫ5 mV for Na v 1.3. Test currents were normalized and plotted against the conditioning voltage. The steadystate properties for Na v 1.7 and Na v 1.3 in the absence of OD1 (f, F) are shown on the same graph as in the presence of OD1 (Ⅺ, E). Each data point is an average of at least three experiments. The dashed lines are Boltzmann fits. See Table 1 (Table 1) . However, OD1 has clear effects on the completeness of the inactivation. At 0 mV, the availability was 0.53 Ϯ 0.65% in control conditions but 9.4 Ϯ 0.5% in the presence of 50 nM OD1. For Na v 1.3, 500 nM OD1 induced a nonsignificant small depolarizing shift of 3 mV in the V 1/2 of inactivation (p Ͻ 0.05). V 1/2 and slope factors are depicted in Table 1 . As for Na v 1.7, the inactivation of Na v 1.3 in the presence of OD1 is less complete. The percentage of available channels at Ϫ5 mV was 3.3 Ϯ 0.5% in control conditions and 13.9 Ϯ 1% in the presence of 500 nM OD1.
The effect of OD1 on the activation of the two channels was also investigated. The activation curves were derived from the I-V curves. The activation curves of Na v 1.7 and Na v 1.3 in the absence and presence of OD1 were plotted against voltage (Fig. 4 , top, Na v 1.7; bottom, Na v 1.3). For Na v 1.7, 50 nM OD1 caused a 3-mV hyperpolarizing shift of the midpoint of activation. This shift was not significant (p Ͻ 0.05, Table 1 ), but became larger with higher concentrations of OD1 (data not shown). For Na v 1.3, 500 nM OD1 did not affect the activation process (Table 1) .
Effect of OD1 On the Recovery from Fast Inactivation of Na v 1.7. Next, we examined the recovery from fast inactivation in the absence and presence of OD1. Figure 5 shows the fraction of recovered Na v 1.7 channels for control conditions and in the presence of 100 nM OD1 (mean Ϯ S.E.M., n ϭ 3). The two time constants (see inset) are 8.8 Ϯ 0.2 and 46.8 Ϯ 5.3 ms for the control condition and 1.8 Ϯ 0.2 and 11.8 Ϯ 0.3 ms in the presence of OD1, indicating that OD1 accelerates the recovery from fast inactivation of Na v 1.7.
Comparison of OD1 Effects with AahII and BmK M1. To investigate whether the multiple effects were typical for OD1, we compared OD1 with a classic ␣-toxin, AahII from Androctonus australis Hector (Rochat et al., 1972) , and a classic ␣-like toxin, BmK M1 from B. martensii Karsch (Ji et al., 1996) (Fig. 1) . Figure 6 , A and D, shows Na v 1.7 current traces in response to a 100-ms voltage step to 0 mV in control conditions and in the presence of 50 nM AahII or 50 nM BmK M1. Like OD1, both AahII and BmK M1 induce 1) an increase in peak current, 2) an impairment of the inactivation process, and 3) a large persistent current at the end of 100-ms voltage step, indicating that these three effects are not unique to OD1. The absolute values of the parameter I 30ms /I peak were 0.17 Ϯ 0.01 for 50 nM OD1, 0.18 Ϯ 0.02 for 50 nM AahII, and 0.12 Ϯ 0.01 for 50 nM BmK M1. Those values represent the mean Ϯ S.E.M. of at least three experiments. For comparison, under control conditions, this value was 0.048 Ϯ 0.009 (n ϭ 9), implying that the ratio I 30ms /I peak increases 3.6-fold for 50 nM OD1, 3.8-fold for 50 nM AahII, and 2.5-fold for 50 nM BmK M1. Figure 6 , B and E, shows the corresponding current-voltage relation recorded from the same oocyte as in Fig. 6 , A and D, respectively. At a concentration of 50 nM, both toxins substantially increase the area under the I-V curve. For this representative example, the increase in the AUC was 200% for AahII and 160% for BmK M1.
The effects of 50 nM AahII and BmK M1 on the gating of Na v 1.7 are represented in the bottom of Fig. 6 , C and F. Tables 2 (AahII) and 3 (BmK M1) show the corresponding V 1/2 values and slope factors, as determined by fitting the data points to the Boltzman equation. The activation process of Na v 1.7 is not affected by 50 nM AahII or BmK M1, whereas the steady-state inactivation is modified only by AahII. The latter causes a significant (p Ͻ 0.05) depolarizing shift of 5.3 mV in the V 1/2 . Similar to OD1, both toxins reduce the completeness of steady-state inactivation. The percentage of available channels at Ϫ5 mV was 14.5 Ϯ 3.4% in the presence of 50 nM AahII and 9.7 Ϯ 0.4% the presence of 50 nM BmK M1.
In addition, we also investigated the effects of 50 nM AahII and BmK M1 on Na v 1.3 and Na v 1.8. At this concentration, Na v 1.8 was affected by neither AahII (n Ն 5) nor BmK M1 (n Ն 4). In addition, concentrations up to 500 nM were tested Recovery from fast inactivation examined using a standard double-pulse protocol. A 25-ms conditioning pulse to 0 mV to fully fast-inactivate the channel, followed by a hyperpolarizing step to Ϫ100 mV for variable duration (0 -160 ms). Recovery was monitored by measuring the relative peak Na ϩ current elicited by a second pulse to 0 mV and plotted as a function of the interval between the pulses. The average of at least three experiments is depicted for control conditions (f) and in the presence of 100 nM OD1 (Ⅺ). The recovery of the peak amplitude was fitted with a double exponential. The inset shows the time constants for control conditions (filled bar) and in the presence of 100 nM OD1 (open bar). and induced no change in Na v 1.8 currents. Na v 1.3 however is sensitive to 50 nM AahII. Figure 7A shows Na v 1.3 current traces in response to a 100-ms voltage step to Ϫ5 mV in control conditions and in the presence of 50 nM AahII. AahII induces 1) an increase in peak current, 2) an impairment of the inactivation process, and 3) a large persistent current at the end of a 100-ms voltage step. The absolute values of the parameter I 30ms /I peak were 0.23 Ϯ 0.02 in control and 0.70 Ϯ 0.01 in the presence of 50 nM AahII (n Ն 4), resulting in a 3.1-fold increase of the I 30ms /I peak ratio. Figure 7B shows the corresponding current-voltage relation recorded from the same oocyte. At a concentration of 50 nM, AahII increases the AUC with 240%. The effects on the activation and steadystate inactivation curves of Na v 1.3 is depicted in Fig. 6C . The corresponding V 1/2 values and slope factors, as determined by fitting the data points to the Boltzman equation, are shown in Table 2 . AahII (50 nM) causes a 8.7-mV hyperpolarizing shift in the V 1/2 for activation. The V 1/2 for steady-state inactivation was not affected, but the completeness of steadystate inactivation changed dramatically in the presence of 50 nM AahII. The percentage of available channels at Ϫ5 mV increased from 3.7 Ϯ 0.5% in control conditions to 53.9 Ϯ 2.9% in the presence of 50 nM AahII. Na v 1.3 was not sensitive to 50 nM BmK M1. Figure 7D shows Na v 1.3 current traces in response to a 100-ms voltage step to Ϫ5 mV in control conditions and in the presence of 50 nM BmK M1. Figure 7E shows the current-voltage curve recorded from the same oocyte, demonstrating that BmK M1 does not affect this channel. Higher concentrations (up to 500 nM) did not induce significant changes in Na v 1.3 currents (data not shown). The activation and steady-state inactivation curves are depicted in Fig. 7F . The corresponding V 1/2 values and slope factors, as determined by fitting the data points to the Boltzman equation, are shown in Table 3 . BmK M1 at a concentration of 50 nM induced no significant (p Ͻ 0.05) in the activation or inactivation parameters.
Discussion
The aim of this study was to examine the effects of the recently discovered scorpion toxin OD1 (Fig. 1) , on three VGSCs involved in pain sensation: Na v 1.3, Na v 1.7, and (squares) were derived from the same family of currents used for the current-voltage relationships. Steady-state inactivation curves (circles) were determined using conditioning pulses to voltages between Ϫ90 and 0 mV and a standard test pulse to 0 mV. Test currents were normalized and plotted against the conditioning voltage. Each data point is an average of four experiments. The dashed lines are Boltzmann fits. See Table 2 
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Na v 1.8. We showed that they had different sensitivities to OD1. Na v 1.7 was 250-fold more sensitive to OD1 than to Na v 1.3, whereas Na v 1.8 was not affected at the tested concentrations. The EC 50 value for modulation of Na v 1.7 is 4.5 nM, demonstrating that OD1 is one of the most potent ligands for Na v 1.7 described at present. OD1 was recently characterized as an ␣-like toxin. Jalali et al. showed that the inactivation process of the insect VGSC, para, was severely hampered by 200 nM OD1. However, the mammalian VGSCs Na v 1.2 and Na v 1.5 were not at all affected by concentrations up to 1 M (Jalali et al., 2005) . Unlike OD1, the other toxins known as Na v 1.7 modulators do not exhibit this selectivity pattern. Heinemann and coworkers (Chen and Heinemann, 2001; demonstrated that the scorpion toxin Lqh-3 (Fig. 1) from L. quinquestriatus hebraeus impairs fast inactivation of Na v 1.7 with an EC 50 value of 14 nM but that Na v 1.5 is even more sensitive (EC 50 2.5 nM). Lqh-2 (Fig. 1) was shown to restrain the fast inactivation process of Na v 1.7 with an EC 50 value of 32 nM, whereas the values for Na v 1.2 and Na v 1.5 were 1.8 and 12 nM, respectively. In addition, the tarantula peptides ProTx-I and ProTx-II inhibit the activation of Na v 1.7 as well as other VGSCs (Na v 1.2, Na v 1.5, and Na v 1.8) with IC 50 values below 100 nM (Middleton et al., 2002) .
This work demonstrates that OD1 affects the gating of Na v 1.7 at low nanomolar concentrations, resulting in 1) an impairment of fast inactivation, 2) a marked increase in peak Na ϩ influx, and 3) a substantial persistent Na ϩ current, compared with control conditions. This noninactivating current is reflected by the failure of steady state availability to reach zero, even at positive potentials. As a consequence, in the presence of OD1, channels will conduct much more inward Na ϩ current than in the absence of the toxin. To examine whether these multiple effects are typical for OD1, it was compared with a classic ␣-toxin, AahII (Fig. 1) from A. australis Hector (Rochat et al., 1972) , and a classic ␣-like toxin, BmK M1 (Fig. 1) from B. martensii Karsch (Ji et al., 1996) .
Our data show that these multiple effects on Na v 1.7 are not exceptional for OD1, because the effects of AahII and BmK M1 were similar to those of OD1. However, in contrast to those toxins, OD1 is unique in its selectivity for Na v 1.7 over Na v 1.2, Na v 1.3, and Na v 1.5. Unlike OD1, AahII is a potent modulator of rat brain sodium channels, and it was shown that 0.5 nM concentrations of this toxin have dramatic effects on the inactivation process (Gordon et al., 1996) . Our data demonstrate that 50 nM AahII severely hampers fast inactivation of Na v 1.3. In addition, BmK M1 impairs the inactivation of Na v 1.5 channels with an EC 50 value of 195 nM (native toxin) (Goudet et al., 2001) or 500 nM (recombinant BmK M1) (Liu et al., 2005) .
Some scorpion neurotoxins show specificity for insect or mammalian VGSCs and others are able to discriminate between VGSC subtypes. This selectivity is attributed to differences in active sites on the toxins and to variations in receptor binding sites on distinct VGSCs. All scorpion ␣-toxins bind to receptor site 3, which involves the extracellular loop between segments S3 and S4 of domain IV of the VGSC (Rogers et al., 1996) and the extracellular loops S5-S6 of domain I and IV (Tejedor and Catterall, 1988; Thomson and Catterall, 1989) . Mutagenesis within the external linker S3-S4 in domain IV of rat Na v 1.2 identified a negatively charged residue, Glu1613 as a major determinant that affects the binding (Rogers et al., 1996) . The authors propose that nonacidic residues in the extracellular loops S5-S6 of domain I and IV may contribute to ␣-scorpion toxin binding by providing unique determinants that are involved in the interactions between the toxin and the channel. To understand the pharmacological selectivity pattern of OD1, we compared the amino acid sequences of receptor site 3 of Na v 1.7 with Na v 1.2, Na v 1.3, Na v 1.5, and the insect sodium channel para. Aligning the sequences, using the ClustalW algorithm, revealed no striking differences in S5-S6 of domain I and S3-S4 of domain IV. In S5-S6 of domain IV, Na v 1.7 and para have an asparagine at position 1674, whereas Na v 1.2, Na v 1.3, and Na v 1.5 have an aspartic acid. This asparagine probably contributes to the sensitivity of Na v 1.7 and para to OD1. Finally, it is noteworthy that Na v 1.8, which seems to be resistant to all tested scorpion ␣-toxins, has an uncharged hydrophobic amino acid, alanine, at the corresponding position of Glu1613 in Na v 1.2 in the S3-S4 extracellular loop of domain IV. This might explain the resistance of Na v 1.8 to scorpion ␣-toxins. VGSCs open when the membrane potential is depolarized and close on repolarization, but also on continuous depolarization by a process termed inactivation, which leaves the channel refractory (i.e., unable to open again for a period of time). For the process of fast inactivation, this time is of the millisecond range but it can last much longer (up to seconds) in a different slow type of inactivation. Fast inactivation is highly vulnerable and is known to be affected by many agents, including toxins (Ulbricht, 2005) . Our data show that on the one hand, OD1 impairs the process of fast inactivation of Na v 1.7; on the other hand, it accelerates the recovery from fast inactivation. This is in accordance with the work of Hank and coworkers, who demonstrated that the site 3 sea anemone toxin Anthopleurin B prolongs the macroscopic inactiva- Fig. 7 . Effects of AahII and BmK M1 on Na v 1.3. Top, representative whole-cell Na ϩ currents of an oocyte expressing Na v 1.3 channels, in response to a 100-ms voltage pulse to V max (Ϫ5 mV). Solid lines represent control currents, dashed lines represent the current in the presence of 50 nM AahII (A) and BmK M1 (D). Arrow indicates zero current. B and E show the corresponding current-voltage relationships in control conditions (f) and in the presence of toxin (Ⅺ), recorded from the same oocyte as in A and D, respectively. C and F depict the activation and steady-state inactivation curves in control conditions (filled symbols) and in the presence of toxin (open symbols). Activation curves (squares) were derived from the same family of currents used for the current-voltage relationships. Steady-state inactivation curves (circles) were determined using conditioning pulses to voltages between Ϫ90 and Ϫ5 mV and a standard test pulse to Ϫ5 mV. Test currents were normalized and plotted against the conditioning voltage. Each data point is an average of four experiments. The dashed lines are Boltzmann fits. See Tables 2 and 3 for V 1/2 values and slope factors. tion and increases the rate of whole-cell recovery of cardiac and neuronal VGSCs (Benzinger et al., 1997) . They propose that the noninactivating current in the presence of toxin arises from an O % I equilibrium that partially favors the open state but that the overall rate of I 3 O recovery is still not sufficiently large to cause appreciable numbers of channels to recover through the open state during repolarization. Nonetheless, toxin treatment does augment recovery from inactivation. The authors suggest that both of these observations can be rationalized under the assumption that the toxin destabilizes the terminal inactivated state of the channel. Open-state inactivation is slowed, producing the well-known prolongation of macroscopic inactivation and increase in mean open time. This slowing, combined with a possible augmentation of the open-state recovery rate I 3 O, produces the observed plateau current. Finally, destabilization of the final inactivated state enhances the recovery from closed state inactivation (Benzinger et al., 1997) . We assume the effects of OD1 on Na v 1.7 could be explained in a similar way. The increase in peak current observed in the presence of OD1 would then be compatible with an enhanced recovery from closed-state inactivation.
The VGSC Na v 1.7 has been implicated in several pathophysiological conditions, as acute inflammatory pain (Nassar et al., 2004) , erythermalgia Michiels et al., 2005) , and prostate cancer (Diss et al., 2005) . Mainly because of its role in pain, Na v 1.7 has become a interesting therapeutic target. At first one would logically think about ion channel blockers, but examination of certain sodium channelopathies suggests that other ways to inhibit the propagation of action potential trains in neurons may exist. Mutations in VGSC genes have been identified as the cause of epilepsy, periodic paralysis, muscle stiffness (myotonia), or cardiac arrhythmia. For the majority of these, the mutations produce mis-sense substitutions that result in functional channels with subtle changes in the voltage dependence of channel opening and closing (gating) (Cannon, 2002) . Extensively studied examples of sodium channelopathies are the autosomal-dominantly inherited forms of myotonia and periodic paralysis. Missense mutations in SCN4A, the Na ϩ channel ␣ subunit of skeletal muscle, predominantly cause gain-of-function defects in which inactivation is partially disrupted or, in a few cases, activation is enhanced. The end result is that mutant channels conduct more inward Na ϩ current than wild-type ones. It is noteworthy that the aberrant inward current can result in pathologically enhanced excitability (small persistent Na ϩ currents 1-2% of the peak cause bursts of repetitive muscle fiber discharges producing sustained myotonic stiffness), whereas slightly more severe defects of inactivation (Ͼ3%) induce a loss of muscle excitability that manifests as flaccid weakness as a result of prolonged depolarization-induced reduction in Na ϩ channel availability (Cannon, 2000) . We think this last situation might be comparable with the modulation of Na v 1.7 by OD1.
In correlation with proinflammatory, hyperalgesic agents such as serotonin, prostaglandin E 2 and adenosine, which cause abnormal bursting activity in primary sensory neurons, OD1 causes a dose-dependent increase in the amplitude of Na ϩ currents, accompanied by a leftward shift in the voltage-dependence of activation (Gold et al., 1996) . However, in sharp contrast to the aforementioned hyperalgesic agents, OD1 impairs the fast inactivation process and results in an incomplete inactivation in steady-state conditions. We presume that the persistent inward Na ϩ current may lead to a sustained depolarization of the cell membrane in vivo. Therefore, the remaining Na v 1.7 channels that were not affected by OD1 would be trapped in the inactivated state, resulting in the loss of electrical excitability of nociceptor neurons. A similar mechanism was proposed to explain feeling of numbness described after contact of skin with the VGSC modulator batrachotoxin (Bosmans et al., 2004) .
In conclusion, the present study shows that the scorpion toxin OD1 is a potent modulator of Na v 1.7. Low nanomolar concentrations of this toxin impair the steady-state fast inactivation process, enhance the recovery from fast inactivation, increase the peak Na ϩ current, and give rise to a substantial persistent Na ϩ current. At these concentrations, other mammalian VGSCs (Na v 1.2, Na v 1.3, Na v 1.5, and Na v 1.8) were not affected.
